MedPath

Caelyx

Brand Name: Caelyx

Generic Name: Doxorubicin hydrochloride

Expiring Soon
Registration Number

DR-XY47160

Dosage Form

Pegylated Liposomal Concentrate Suspension for Solution for Injection for I.V. Infusion

Issuance Date

February 2, 2021

Expiry Date

February 2, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2 mg/mL
PackagingType I clear glass tubing vial with bromobutyl stopper and aluminum seal with flip-off cap x 10 mL and 25 mL (net content). Box of 1's

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Doxorubicin hydrochlorideActive
Monograph: Doxorubicin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform